Jeffrey L. Rutherford - 29 Jan 2022 Form 4 Insider Report for DIEBOLD NIXDORF, Inc (DBD)

Role: EVP and CFO
Signature: Jonathan B. Leiken, Attorney-in-fact for Jeffrey L. Rutherford
Issuer symbol: DBD
Transactions as of: 29 Jan 2022
Net transactions value: -$160,987
Form type: 4
Filing time: 31 Jan 2022, 15:44:56 UTC
Next filing: 08 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DBD	Common Shares	Tax liability	$123,886	-14,078	-5.6%	$8.80	236,386	29 Jan 2022	Direct	F1, F2
transaction	DBD	Common Shares	Tax liability	$37,101	-4,216	-1.8%	$8.80	232,170	30 Jan 2022	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	DBD	Non-Qualified Stock Option						68,572	29 Jan 2022	Common Shares	68,572	$4.08	Direct	F3
holding	DBD	Non-Qualified Stock Option						18,898	29 Jan 2022	Common Shares	18,898	$11.96	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares withheld pursuant to exercise of tax withholding right under the 2017 Equity and Performance Incentive Plan - Restricted Share Award
F2	Number includes restricted stock units.
F3	Granted under the 2017 Equity and Performance Incentive Plan; option is generally exercisable in annual increments of 1/3, 1/3, 1/3 beginning one year from the date of grant.